| __timestamp | Celldex Therapeutics, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20622000 | 6795238 |
| Thursday, January 1, 2015 | 33837000 | 7454247 |
| Friday, January 1, 2016 | 35979000 | 10345862 |
| Sunday, January 1, 2017 | 25003000 | 16984203 |
| Monday, January 1, 2018 | 19269000 | 16187290 |
| Tuesday, January 1, 2019 | 15426000 | 9299233.54 |
| Wednesday, January 1, 2020 | 14456000 | 19232000 |
| Friday, January 1, 2021 | 20488000 | 23611000 |
| Saturday, January 1, 2022 | 27195000 | 26700000 |
| Sunday, January 1, 2023 | 30914000 | 28215000 |
Cracking the code
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Celldex Therapeutics, Inc. and Summit Therapeutics Inc. have showcased distinct spending patterns. From 2014 to 2023, Celldex's SG&A expenses have seen a steady increase, peaking in 2016 and 2023, with a notable 50% rise from 2014 to 2023. In contrast, Summit Therapeutics displayed a more volatile pattern, with a significant surge in 2020, marking a 182% increase from its 2014 figures. This divergence highlights differing strategic priorities and market responses. As the biotech landscape evolves, understanding these financial strategies offers valuable insights into each company's operational focus and market positioning.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: United Therapeutics Corporation vs Summit Therapeutics Inc.
Neurocrine Biosciences, Inc. and Summit Therapeutics Inc.: SG&A Spending Patterns Compared
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Summit Therapeutics Inc. vs Merus N.V. Trends and Insights
Summit Therapeutics Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Bausch Health Companies Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
MannKind Corporation and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. or Evotec SE: Who Manages SG&A Costs Better?